Viviani S
Vaccines (Basel). 2022; 10(4).
PMID: 35455366
PMC: 9027557.
DOI: 10.3390/vaccines10040617.
Kilian M, Husby S, Andersen J, Moldoveanu Z, Skov Sorensen U, Reinholdt J
mBio. 2022; 13(3):e0055022.
PMID: 35420467
PMC: 9239265.
DOI: 10.1128/mbio.00550-22.
Ferlito C, Visco V, Biselli R, Cattaruzza M, Carreras G, Salerno G
Biomedicines. 2022; 10(1).
PMID: 35052686
PMC: 8773007.
DOI: 10.3390/biomedicines10010006.
van Ravenhorst M, van der Klis F, van Rooijen D, Sanders E, Berbers G
BMC Med Res Methodol. 2019; 19(1):1.
PMID: 30611213
PMC: 6321721.
DOI: 10.1186/s12874-018-0650-3.
van Ravenhorst M, Den Hartog G, van der Klis F, van Rooijen D, Sanders E, Berbers G
PLoS One. 2018; 13(4):e0191261.
PMID: 29672552
PMC: 5908077.
DOI: 10.1371/journal.pone.0191261.
A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
Manigart O, Trotter C, Findlow H, Assefa A, Mihret W, Moti Demisse T
PLoS One. 2016; 11(2):e0147928.
PMID: 26872255
PMC: 4752490.
DOI: 10.1371/journal.pone.0147928.
Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac.
Tang Y, Plikaytis B, Preziosi M, Borrow R
Clin Infect Dis. 2015; 61 Suppl 5:S531-9.
PMID: 26553685
PMC: 4639503.
DOI: 10.1093/cid/civ601.
Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.
Diallo A, Sow S, Idoko O, Hirve S, Findlow H, Preziosi M
Clin Infect Dis. 2015; 61 Suppl 5:S521-30.
PMID: 26553684
PMC: 4639491.
DOI: 10.1093/cid/civ518.
Persistence of antibodies in laboratory staff immunized with quadrivalent meningococcal polysaccharide vaccine.
Elias J, Findlow J, Borrow R, Tremmel A, Frosch M, Vogel U
J Occup Med Toxicol. 2013; 8(1):4.
PMID: 23510399
PMC: 3599363.
DOI: 10.1186/1745-6673-8-4.
Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008.
Trotter C, Yaro S, Njanpop-Lafourcade B, Drabo A, Kroman S, Idohou R
PLoS One. 2013; 8(2):e55486.
PMID: 23457471
PMC: 3573051.
DOI: 10.1371/journal.pone.0055486.
Age-related immunity to meningococcal serogroup C vaccination: an increase in the persistence of IgG2 correlates with a decrease in the avidity of IgG.
de Voer R, van der Klis F, Schepp R, Rijkers G, Sanders E, Berbers G
PLoS One. 2011; 6(8):e23497.
PMID: 21887261
PMC: 3160848.
DOI: 10.1371/journal.pone.0023497.
Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine.
de Voer R, Mollema L, Schepp R, De Greeff S, van Gageldonk P, de Melker H
PLoS One. 2010; 5(8):e12144.
PMID: 20730091
PMC: 2921331.
DOI: 10.1371/journal.pone.0012144.
Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice.
Jin Z, Bohach G, Shiloach J, Norris S, Freedberg D, Deobald C
Infect Immun. 2005; 73(12):7887-93.
PMID: 16299279
PMC: 1307062.
DOI: 10.1128/IAI.73.12.7887-7893.2005.
Immunogenicity of meningococcal ACYW135 polysaccharide vaccine in Saudi children 5 to 9 years of age.
Khalil M, Al-Mazrou Y, Balmer P, Bramwell J, Andrews N, Borrow R
Clin Diagn Lab Immunol. 2005; 12(10):1251-3.
PMID: 16210493
PMC: 1247841.
DOI: 10.1128/CDLI.12.10.1251-1253.2005.
Chemical structure, conjugation, and cross-reactivity of Bacillus pumilus Sh18 cell wall polysaccharide.
Kubler-Kielb J, Coxon B, Schneerson R
J Bacteriol. 2004; 186(20):6891-901.
PMID: 15466043
PMC: 522182.
DOI: 10.1128/JB.186.20.6891-6901.2004.
Preparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.
Jin Z, Chu C, Robbins J, Schneerson R
Infect Immun. 2003; 71(9):5115-20.
PMID: 12933854
PMC: 187323.
DOI: 10.1128/IAI.71.9.5115-5120.2003.
Direct and rapid identification and genogrouping of meningococci and porA amplification by LightCycler PCR.
Molling P, Jacobsson S, Backman A, Olcen P
J Clin Microbiol. 2002; 40(12):4531-5.
PMID: 12454147
PMC: 154616.
DOI: 10.1128/JCM.40.12.4531-4535.2002.
Update on meningococcal disease with emphasis on pathogenesis and clinical management.
van Deuren M, Brandtzaeg P, van der Meer J
Clin Microbiol Rev. 2000; 13(1):144-66, table of contents.
PMID: 10627495
PMC: 88937.
DOI: 10.1128/CMR.13.1.144.
Vibrio cholerae O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation.
Yildiz F, Schoolnik G
Proc Natl Acad Sci U S A. 1999; 96(7):4028-33.
PMID: 10097157
PMC: 22414.
DOI: 10.1073/pnas.96.7.4028.
Characterization of the gene cassette required for biosynthesis of the (alpha1-->6)-linked N-acetyl-D-mannosamine-1-phosphate capsule of serogroup A Neisseria meningitidis.
Swartley J, Liu L, Miller Y, Martin L, Edupuganti S, Stephens D
J Bacteriol. 1998; 180(6):1533-9.
PMID: 9515923
PMC: 107054.
DOI: 10.1128/JB.180.6.1533-1539.1998.